Reliance Capital aims to more than double its customer base to 50 million over the next 3-5 years. The company currently has a customer base of 20 million across insurance, mutual funds, brokerage and other financial services. In Q1 FY2015-16, Reliance Capital reported total income of Rs. 9,998 crore, up 12% year-over-year, while net profit stood at Rs. 1,101 crore, up 10% year-over-year. Technical indicators show the stock is in an uptrend and analysts recommend buying the stock between Rs. 542-545 for a target of Rs. 555 with a stop loss of Rs. 537.

1. SEBI Certified – Research Analyst www.choiceindia.com
Global View
India Update
Today’s Event/ Stock in News
Accordingtomediareports,Anil Ambani ledReliance Capital is targetingan over two-foldincrease inits customer base to50 million over the
next three-five years and the financial services firm is stepping up efforts to fulfill its spectacular growth aspirations which are expected to
resultinimmensevaluecreationforthecompany’sshareholders.Thecompanywhichhaspresenceininsurance,mutualfund,brokerageand
consumerandhomefinance,currentlyboastsofacustomerbaseof20million.ThecompanypostedatotalincomeofRs9,998croreinQ1FY
2015-16,upby12percentfromthepreviousyearwhileitsnetprofitforthesamefinancialyearstoodatRs1,101crore,up10percent.
Technical Outlook: On daily chart, stock has formed long bull candlestick with above average volume, which indicates for accentuated
buying activity during last trading sessions. Moreover, stock hasbeen trading inahigher top higher bottom formation since lastmany days
and it seems that stock could further continue its ongoing move. A momentum indicator RSI reading is at 81.10 level with positive
crossover, which point out for positive breath in the stock. So for trading perspective, one could Buy in range of 542-545 for Target of 555
withSLof537.
RELCAPITAL
CADILAHC
SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website
Morning Tea
06th Sep 2016
Buy in range of 383-385 for Target of 394 with SL of 379
Buy in range of 542-545 for Target of 555 with SL of 537
Drug firm Cadila Healthcare Ltd on Friday said it has received an Establishment Inspection Report (EIR) from the US health regulator, USFDA,
for its manufacturing plant in Ahmedabad. “The receipt of EIR indicates the successful closure of the inspection points raised. It may be
mentioned that this plant is a separate manufacturing unit and does not form a part of the Moraiya formulations manufacturing facility,” it
added.
Technical Outlook: Ondailychart, stock has taken supportof its lower band ofrising wedge pattern,which indicates for strength inthe
stock.Moreover,stockhasbeentradingwithcontinuoussupportofits21day movingaverage whichisplacedat374.50 levelwhichshows
thatnear termtrendisup.AmomentumindicatorRSIreadingisat58.90levelwithpositivecrossoverwhichpointoutforpositive breathin
thestock.Sofortradingperspective,onecouldBuyinrangeof383-385forTargetof394withSLof379.
Asian shares edged up on Tuesday but were mostly in a holding pattern after Monday's US holiday, as investors awaited a policy decision
from the Reserve Bank of Australia. European stocks touched an eight-month high in choppy trading .SXEP .SXPP then reversed as trading
wound down in the absence of US markets, which were closed for Labor Day. MSCI's broadest index of Asia-Pacific shares outside Japan
.MIAPJ0000PUS was up 0.1 percent, while Australian shares slipped 0.3 percent ahead of the RBA's announcement. Japan's Nikkei stock
index was up 0.1 percent, with the dollar steady on the day against its Japanese counterpart at 103.47 yen. The Indian equity market is
expectedtoopenflattodaytrackingAsianindices.SGXNiftyistradingat8906.50downby1points.
US stocks advanced as a weaker-than-expected payrolls report tamped down expectations for a September rate hike from the US Federal
Reserve, although hawkish comments from another Fed official kept expectations for one this year intact. US nonfarm payrolls rose by
151,000 jobs in August after an upwardly revised 275,000 increase in July, with job cuts in manufacturing and construction, the Labor
Departmentsaid.EconomistspolledbyReutershadforecastpayrollsrisingby180,000lastmonth.TraderstrimmedtheprobabilityofaFed
rate hike this month to21 percent from the 24-percent chance on Thursday, according to CMEGroup's FedWatch program.However, the
odds for a December rate increase edged up to 54.2 percent from 53.6 percent the previous day. The Dow Jones industrial average rose
72.66points,or0.39percent,to18,491.96,theS&P500 gained9.12points,or0.42percent,to2,179.98andtheNasdaqCompositeadded
22.69points,or0.43percent,to5,249.90.

2. SEBI Certified – Research Analyst www.choiceindia.comSEBI Certified – Research Analyst www.choiceindia.com
Morning Tea
06th Sep 2016
SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website
JK Paper Limited; Dividend Re.0.50 Per Share
Hindalco Industries Limited; Dividend - Re 1/- Per Share
Orient Bell Limited; Annual General Meeting/Dividend Re 0.50 Per Share
Techno Electric & Engineering Company Limited; Bonus 1:1
Bliss GVS Pharma Limited; Annual General Meeting/Dividend Re 0.50 Per Share
Datamatics Global Services Limited; Annual General Meeting/ Dividend - Re 0.25/- Per Share
Result Calendar:
ESL, HMT, JINDALPOLY, KOLTEPATIL, NITINFIRE, OIL & SITINET
Corporate Action / Result Calendar
Bulk Deal
Security in Ban
Sr. No. Deal Date Script Code Security Name Client Name Deal Type Quantity Price
1 1/9/2016 500003 AEGISLOG INFRASTRUCTURE INDIA HOLDINGS FUND LLC S 7500000 130.03
2 1/9/2016 500003 AEGISLOG MOTILAL OSWAL ASSET MANAGEMENT COMPA B 4000000 130.00
3 1/9/2016 532529 NDTV ERISKA INVESTMENT FUND LTD B 2851894 86.00
4 1/9/2016 532529 NDTV OSWAL GREENTECH LTD. S 2851894 86.00
5 1/9/2016 530187 ATHARVENT RHEA NITTEN JAJU S 2172000 2.25
6 1/9/2016 531739 GENNEX MANPHOOL EXPORTS LIMITED S 1197854 7.00
7 1/9/2016 531934 SUPREMETEX BP FINTRADE PRIVATE LIMITED S 1176452 10.64
7 1/9/2016 531934 SUPREMETEX BP FINTRADE PRIVATE LIMITED B 1176452 10.63
7 1/9/2016 531934 SUPREMETEX SANTOSH GAJANDER SINGH S 1114242 10.64
7 1/9/2016 531934 SUPREMETEX SANTOSH GAJANDER SINGH B 1114242 10.65
CEATLTD, IBREALEST, JINDALSTEL, KSCL & RCOM

3. SEBI Certified – Research Analyst www.choiceindia.com
Contact Us
www.choiceindia.com
www.choiceindia.comcustomercare@choiceindia.com
Disclaimer
This is solely for information of clients of Choice Broking and does not construe to be an investment advice. It is also not intended as an offer or solicitation for the purchase and sale of any financial
instruments. Any action taken by you on the basis of the information contained herein is your responsibility alone and Choice Broking its subsidiaries or its employees or associates will not be liable in
any manner for the consequences of such action taken by you. We have exercised due diligence in checking the correctness and authenticity of the information contained in this recommendation, but
Choice Broking or any of its subsidiaries or associates or employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the
information contained in this recommendation or any action taken on basis of this information. Technical analysis studies market psychology, price patterns and volume levels. It is used to forecast
future price and market movements. Technical analysis is complementary to fundamental analysis and news sources. The recommendations issued herewith might be contrary to recommendations
issued by Choice Broking in the company research undertaken as the recommendations stated in this report is derived purely from technical analysis. Choice Broking has based this document on
information obtained from sources it believes to be reliable but which it has not independently verified; Choice Broking makes no guarantee, representation or warranty and accepts no responsibility
or liability as to its accuracy or completeness. The opinions contained within the report are based upon publicly available information at the time of publication and are subject to change without
notice. The information and any disclosures provided herein are in summary form and have been prepared for informational purposes. The recommendations and suggested price levels are intended
purely for trading purposes. The recommendations are valid for the day of the report however trading trends and volumes might vary substantially on an intraday basis and the recommendations may
be subject to change. The information and any disclosures provided herein may be considered confidential. Any use, distribution, modification, copying, forwarding or disclosure by any person is
strictly prohibited. The information and any disclosures provided herein do not constitute a solicitation or offer to purchase or sell any security or other financial product or instrument. The current
performance may be unaudited. Past performance does not guarantee future returns. There can be no assurance that investments will achieve any targeted rates of return, and there is no guarantee
against the loss of your entire investment.
POTENTIAL CONFLICT OF INTEREST DISCLOSURE (as on date of report) Disclosure of interest statement – • Analyst interest of the stock /Instrument(s): - No. • Firm interest of the stock /
Instrument (s): - No.
SEBI Certified – Research Analyst www.choiceindia.com
Research Team
Mr. Sumeet Bagadia Associate Director
Kkunal Parar Sr. Research Associate
Amit Pathania Research Associate
Vikas Chaudhari Research Associate
Kapil Shah Research Associate
Rajnath Yadav Research Associate
Satish Kumar Research Associate
Morning Tea
06th Sep 2016
SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website
Kunal Parmar
Digitally signed by Kunal Parmar
DN: cn=Kunal Parmar, o=Choice Equity Broking
Pvt Ltd., ou=Research Dept,
email=kunal.parmar@choiceindia.com, c=IN
Date: 2016.09.06 08:25:17 +05'30'